Baidu
map

内分泌科指南

订阅

MedSci主页 / 所有栏目 / 内分泌科指南

2019 TES临床实践指南：女性绝经后骨质疏松症的药物治疗

2019-03-25 美国内分泌学会 J Clin Endocrinol Metab. 2019 Mar 25.

绝经骨质疏松症药物治疗

2019年3月，美国内分泌学会(TES)发布了女性绝经后骨质疏松症的药物治疗指南，文章主要目的是针对女性绝经后骨质疏松症的药物治疗提出循证管理指南，涉及药物包括二膦酸盐，地诺单抗，特立帕肽以及abaloparatide，选择性雌激素受体调节剂，更年期激素治疗和替勃隆，降钙素，钙剂及维生素D。

中文标题：

2019 TES临床实践指南：女性绝经后骨质疏松症的药物治疗

英文标题：

Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline.

发布机构：

美国内分泌学会

发布日期：

2019-03-25

简要介绍：

2019年3月，美国内分泌学会(TES)发布了女性绝经后骨质疏松症的药物治疗指南，文章主要目的是针对女性绝经后骨质疏松症的药物治疗提出循证管理指南，涉及药物包括二膦酸盐，地诺单抗，特立帕肽以及abaloparatide，选择性雌激素受体调节剂，更年期激素治疗和替勃隆，降钙素，钙剂及维生素D。 

拓展指南：与骨质疏松相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2019 TES临床实践指南：女性绝经后骨质疏松症的药物治疗)] GetToolGuiderByIdResponse(projectId=1, id=c08df1c001e239c3, title=2019 TES临床实践指南：女性绝经后骨质疏松症的药物治疗, enTitle=Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline., guiderFrom=J Clin Endocrinol Metab. 2019 Mar 25., authorId=null, author=, summary=2019年3月，美国内分泌学会(TES)发布了女性绝经后骨质疏松症的药物治疗指南，文章主要目的是针对女性绝经后骨质疏松症的药物治疗提出循证管理指南，涉及药物包括二膦酸盐，地诺单抗，特立帕肽以及abaloparatide，选择性雌激素受体调节剂，更年期激素治疗和替勃隆，降钙素，钙剂及维生素D。 , cover=, journalId=null, articlesId=null, associationId=129, associationName=美国内分泌学会, associationIntro=美国内分泌学会（The Endocrine Society）成立于1916年，是激素研究和内分泌学临床实践世界最大、最古老，也是最活跃的机构，致力于提升公众和其他医务人员对于内分泌学的了解，提高内分泌学者在国家科研和医疗政策层面的影响。学会现拥有来自100多个国家的约14000名会员，遍布医学、分子生物学、细胞生物学、生物化学、生理学、基因学、免疫学、教育等相关领域，包括临床医生、研究员、教师、学生、内分泌学领域的相关专业人员。学会出版专业期刊和杂志，举办国际会议，为医师提供教育培训项目，发布临床实践指南，积极募集相关研究资助，推动相关政策发展。, copyright=0, guiderPublishedTime=Mon Mar 25 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<div>2019年3月，美国内分泌学会(TES)发布了女性绝经后骨质疏松症的药物治疗指南，文章主要目的是针对女性绝经后骨质疏松症的药物治疗提出循证管理指南，涉及药物包括二膦酸盐，地诺单抗，特立帕肽以及abaloparatide，选择性雌激素受体调节剂，更年期激素治疗和替勃隆，降钙素，钙剂及维生素D。 </div> <div><br> </div>拓展指南：<strong>与<font color=red>骨质疏松</font>相关指南：</strong><br><ul><li><a href="//www.sandwebs.com/guideline/show_article.do?id=d4b9f1c00169582a" title="2019 BSH最佳实践指南：接受类固醇治疗的免疫血小板减少症患者糖皮质激素性骨质疏松症的预防" target=_blank>2019 BSH最佳实践指南：接受类固醇治疗的免疫血小板减少症患者糖皮质激素性骨质疏松症的预防</a></li> <li><a href="//www.sandwebs.com/guideline/show_article.do?id=d25601c00168e149" title="中国老年骨质疏松症诊疗指南（2018）" target=_blank>中国老年骨质疏松症诊疗指南（2018）</a></li> <li><a href="//www.sandwebs.com/guideline/show_article.do?id=63a9f1c001681987" title="2018 韩国指南：糖皮质激素性骨质疏松的预防和治疗" target=_blank>2018 韩国指南：糖皮质激素性骨质疏松的预防和治疗</a></li> <li><a href="//www.sandwebs.com/guideline/show_article.do?id=148f91c001650591" title="中国骨质疏松性骨折围手术期处理专家共识（2018）" target=_blank>中国骨质疏松性骨折围手术期处理专家共识（2018）</a></li> <li><a href="//www.sandwebs.com/guideline/show_article.do?id=1da9c1c001609e5e" title="2018 USPSTF建议声明：筛查骨质疏松预防骨折" target=_blank>2018 USPSTF建议声明：筛查骨质疏松预防骨折</a></li> 更多信息请点击：<a href="//www.sandwebs.com/guideline/list.do?q=%E9%AA%A8%E8%B4%A8%E7%96%8F%E6%9D%BE" target=_blank>有关骨质疏松更多指南</a></ul>, tagList=[TagDto(tagId=1512, tagName=绝经), TagDto(tagId=644, tagName=骨质疏松症), TagDto(tagId=1113, tagName=药物治疗)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=10, categoryName=骨科, tenant=100), CategoryDto(categoryId=21067, categoryName=梅斯医学-骨质疏松网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7599, appHits=420, showAppHits=8, pcHits=4732, showPcHits=3449, likes=156, shares=16, comments=3, approvalStatus=1, publishedTime=Sat Apr 13 22:23:34 CST 2019, publishedTimeString=2019-03-25, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sat Apr 13 22:23:34 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 15:58:40 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 TES临床实践指南：女性绝经后骨质疏松症的药物治疗)])
2019 TES临床实践指南：女性绝经后骨质疏松症的药物治疗
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1214755, encodeId=87131214e5531, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 19:55:49 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364639, encodeId=69993646395c, content=谢谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/14/396c3339a85541f445117ab73356e2b4.jpg, createdBy=f84a2352242, createdName=旧时情怀, createdTime=Sun Apr 14 11:47:12 CST 2019, time=2019-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364629, encodeId=ddf0364629a8, content=学习了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sun Apr 14 08:25:56 CST 2019, time=2019-04-14, status=1, ipAttribution=)]
    2022-04-26 su_yi_fei

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1214755, encodeId=87131214e5531, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 19:55:49 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364639, encodeId=69993646395c, content=谢谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/14/396c3339a85541f445117ab73356e2b4.jpg, createdBy=f84a2352242, createdName=旧时情怀, createdTime=Sun Apr 14 11:47:12 CST 2019, time=2019-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364629, encodeId=ddf0364629a8, content=学习了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sun Apr 14 08:25:56 CST 2019, time=2019-04-14, status=1, ipAttribution=)]
    2019-04-14 旧时情怀

    谢谢分享。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1214755, encodeId=87131214e5531, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 19:55:49 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364639, encodeId=69993646395c, content=谢谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/14/396c3339a85541f445117ab73356e2b4.jpg, createdBy=f84a2352242, createdName=旧时情怀, createdTime=Sun Apr 14 11:47:12 CST 2019, time=2019-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364629, encodeId=ddf0364629a8, content=学习了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sun Apr 14 08:25:56 CST 2019, time=2019-04-14, status=1, ipAttribution=)]
    2019-04-14 1ddf0692m34(暂无匿称)

    学习了，谢谢分享

    0

相关指南

2018 法国绝经后骨质疏松症的管理建议（更新版）

法国风湿病学学会(SFR,French Society for Rheumatology) · 2018-04-11

【精品指南】2016绝经期激素疗法全球共识声明（附专家独家视角解读视频）

暂未更新 · 2017-03-24

绝经期激素疗法（2016 修订版）

国际绝经协会(IMS,International Menopause Society) · 2017-03-24

2016 AACE/ACE临床指南：绝经后骨质疏松症的诊断和治疗

美国临床内分泌医师学会(AACE,American Association of Clinical Endocrinologists) · 2016-09-20

Baidu
map
Baidu
map
Baidu
map